Clinical Trials Browser

Phase 1/2 × Liver Neoplasms × atezolizumab × Clear all

NCT06584071 2024-12-16

A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC

Phase 1/2 Not yet recruiting

Gastrointestinal

Liver Neoplasms

NCT06725121 2024-12-16

MacroTrans

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05109052 2023-07-13

Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms